Loading...
Protalix BioTherapeutics aims for $3.20 by year-end amidst strong revenue growth
n/a
n/a
Zwfis's Fair Value
n/a
1Y
4.0%7D
3.4%1Y
4.0%7D
3.4%You can edit this narrative until May 19 5:05 PM. Then, changes will post as Updates.
You can edit this narrative until May 19 5:05 PM. Then, changes will post as Updates.
Author's Valuation
Zwfis's Fair Value